<DOC>
	<DOCNO>NCT00741689</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD1656 single ascend oral dos Japanese healthy male subject</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability After Single Oral Dosing AZD1656 Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese male age ≥20 ≤40 year age Clinically normal physical finding laboratory value judge investigator include negative test Hepatitis B surface antigen , antibody HIV virus antibody Hepatitis C virus Clinically significant illness clinically relevant trauma , judge investigator , within two week first administration IP History psychiatric somatic disease/condition may interfere objective study , judge investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Japanese</keyword>
	<keyword>healthy</keyword>
	<keyword>volunteer</keyword>
</DOC>